Catalent reports 97% of its electricity usage comes from renewable sources

By The Science Advisory Board staff writers

August 3, 2021 -- Catalent, a provider of delivery technologies and development and manufacturing solutions for drugs, biologics, and cell and gene therapies, announced that 97% of its electricity usage is procured from renewable energy sources such as wind, solar, hydroelectric, and biomass.

The announcement aligns with a letter of commitment that Catalent recently signed with the Science-Based Targets initiative (SBTi). SBTi sets actionable, science-based greenhouse gas emission reduction targets to limit global warming. The commitment includes calculating and reducing direct and indirect emissions as the over 1,600 participating companies in SBTi evolve and grow.

The company will purchase renewable energy certificates for all of its operating sites in North America, South America, and Europe, as well as most of its Asia-based facilities.

"As a leader in the growing CDMO [contract development and manufacturing organization] industry, we need to demonstrate our shared commitment, sense of urgency, and value in contributing to the responsibility and long-term sustainability of the entire biopharma sector," said John Chiminski, chair and chief executive officer of Catalent, in a statement.


Copyright © 2021 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.